Abstract

When exposed to vasoactive intestinal peptide (VIP), the human wild type VPAC1 receptor expressed in Chinese hamster ovary (CHO) cells is rapidly phosphorylated, desensitized, and internalized in the endosomal compartment and is not re-expressed at the cell membrane within 2 h after agonist removal. The aims of the present work were first to correlate receptor phosphorylation level to internalization and recycling, measured by flow cytometry and in some cases by confocal microscopy using a monoclonal antibody that did not interfere with ligand binding, and second to identify the phosphorylated Ser/Thr residues. Combining receptor mutations and truncations allowed identification of Ser250 (in the second intracellular loop), Thr429, Ser435, Ser448 or Ser449, and Ser455 (all in the distal part of the C terminus) as candidates for VIP-stimulated phosphorylation. The effects of single mutations were not additive, suggesting alternative phosphorylation sites in mutated receptors. Replacement of all of the Ser/Thr residues in the carboxyl-terminal tail and truncation of the domain containing these residues completely inhibited VIP-stimulated phosphorylation and receptor internalization. There was, however, no direct correlation between receptor phosphorylation and internalization; in some truncated and mutated receptors, a 70% reduction in phosphorylation had little effect on internalization. In contrast to results obtained on the wild type and all of the mutated or truncated receptors that still underwent phosphorylation, internalization of the severely truncated receptor was reversed within 2 h of incubation in the absence of the agonist. Receptor recovery was blocked by monensin, an endosome inhibitor.

Highlights

  • § Recipient of a doctoral fellowship from the Communaute Francaise de Belgique and a grant from the Fonds Lekime-Ropsy

  • We detailed the contribution of the carboxyl-terminal intracellular tail to receptor internalization by studying truncated and mutated human VPAC1 receptors expressed in Chinese hamster ovary (CHO) cells

  • The possible contribution of the G protein receptor kinases to receptor phosphorylation was evaluated on membranes incubated in the presence of radioactive ATP and 1 ␮M vasoactive intestinal peptide (VIP) with 0.1 mM Zn2ϩ and 1 ␮g/ml heparin as inhibitors [12,13,14]

Read more

Summary

Introduction

§ Recipient of a doctoral fellowship from the Communaute Francaise de Belgique and a grant from the Fonds Lekime-Ropsy. The neuropeptide vasoactive intestinal polypeptide (VIP) exerts its multiple regulatory functions through interaction with two high affinity receptors named VPAC1 and VPAC2. These are members of a family of G protein-coupled receptors (GPCRs), designated as Class II or B. If not all, of the GPCRs, both VIP receptors are desensitized, sequestered, and down-regulated after exposure to agonist [3,4,5] This was observed in cells expressing native receptors as well as in transfected Chinese hamster ovary (CHO) cells and HEK 293 cells. We detailed the contribution of the carboxyl-terminal intracellular tail to receptor internalization by studying truncated and mutated human VPAC1 receptors expressed in CHO cells. Single and combined mutations of the Ser/Thr residues indicated the possibility of alternative phosphorylation sites in mutant receptors and indicated that phosphorylation of all of the identified sites was not necessary for receptor internalization

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call